CVR: 36960566
Secondary names: 2care4. ApS, AFORTAS ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The company is owned by 2care4 Group ApS. The company has 7 employees. In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity amounted to DKK 49,944,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udvikle, importere, producere, forhandle og eksportere lægemidler samt anden dermed i naturlig forbindelse stående virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 52.4 mio. | 11.2 mio. | 115.2 mio. | 49.9 mio. | 29 | |
| 2024 | 58.2 mio. | 17.2 mio. | 129.7 mio. | 78.7 mio. | 20 | |
| 2023 | 73.4 mio. | 31.6 mio. | 170.4 mio. | 86.5 mio. | 15 | |
| 2022 | 75.7 mio. | 34.6 mio. | 171 mio. | 74.2 mio. | 12 | |
| 2021 | 55.9 mio. | 29.1 mio. | 127.8 mio. | 44.6 mio. | 15 | |
| 2020 | 32.9 mio. | 15.7 mio. | 72.4 mio. | 15.5 mio. | 12 | |
| 2019 | 8 mio. | -599 t. | 35.4 mio. | -166 t. | 8 | |
| 2018 | 3.3 mio. | -2.9 mio. | 21.3 mio. | 434 t. | 7 | |
| 2017 | -1.5 mio. | -6 mio. | 12.4 mio. | 330 t. | 5 |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Screen owners and management against the Danish FSA's official PEP lists
2care4 Generics ApS has published its annual report for 2025. Gross profit came to DKK 52,415,000, and the net result was DKK 11,207,000.
Contact info changed: new phone: 76101500, new email: [email protected], new website: www.2care4generics.dk (March 26, 2026).
As of March 24, 2026, Erik Sandberg is registered as adm. dir. of 2care4 Generics ApS.
As of March 24, 2026, Ulrik Ernst Rasmussen has stepped down as adm. dir. of 2care4 Generics ApS.
As of December 16, 2025, Henrik Bisgaard Jensen has left the board of directors of 2care4 Generics ApS.
As of December 1, 2025, Thomas Hjarsbæk Rasmussen has stepped down as director of 2care4 Generics ApS.
2care4 Generics ApS has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 66,045,550 DKK.
2care4 Generics ApS has published its annual report for 2024. Gross profit came to DKK 58,190,000, and the net result was DKK 17,193,000.
2care4 Generics ApS has published its annual report for 2023. Gross profit came to DKK 73,414,000, and the net result was DKK 31,564,000.
As of April 25, 2024, Thomas Hjarsbæk Rasmussen is registered as director of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2022. Gross profit came to DKK 75,691,000, and the net result was DKK 34,598,000.
2care4 Generics ApS has published its annual report for 2021. Gross profit came to DKK 55,862,884, and the net result was DKK 29,082,540.
2care4 Generics ApS has published its annual report for 2020. Gross profit came to DKK 32,852,182, and the net result was DKK 15,714,624.
2care4 Generics ApS has published its annual report for 2019. Gross profit came to DKK 7,988,765, and the net result was DKK -599,230.
As of September 6, 2019, Torben Børsting has stepped down as director of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2018. Gross profit came to DKK 3,260,793, and the net result was DKK -2,896,734.
As of May 1, 2019, Torben Børsting has left the board of directors of 2care4 Generics ApS.
As of May 1, 2019, Ulrik Ernst Rasmussen is registered as adm. dir. of 2care4 Generics ApS.
As of May 1, 2019, Toke Værndal has stepped down as adm. dir. of 2care4 Generics ApS.
As of August 31, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2care4 Generics ApS.
As of August 31, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2017. Gross profit came to DKK -1,519,397, and the net result was DKK -6,026,345.
As of February 12, 2018, Torben Børsting has joined the board of directors of 2care4 Generics ApS.
As of February 12, 2018, Henrik Fomsgaard-Knudsen has left the board of directors of 2care4 Generics ApS.
As of February 12, 2018, Toke Værndal is registered as adm. dir. of 2care4 Generics ApS.
As of February 12, 2018, Torben Børsting is registered as director of 2care4 Generics ApS.
As of February 12, 2018, Henrik Fomsgaard-Knudsen has stepped down as adm. dir. of 2care4 Generics ApS.
2care4 Generics ApS has published its interim report for the period July 10, 2015 – December 31, 2016.
As of August 29, 2016, Henrik Fomsgaard-Knudsen has joined the board of directors of 2care4 Generics ApS.
As of August 29, 2016, Toke Værndal has joined the board of directors of 2care4 Generics ApS.
As of August 29, 2016, Henrik Bisgaard Jensen has joined the board of directors of 2care4 Generics ApS.
As of April 19, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2care4 Generics ApS.
As of April 19, 2016, EY Godkendt Revisionspartnerselskab has stepped down as auditor of 2care4 Generics ApS.
As of July 10, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of 2care4 Generics ApS.
As of July 10, 2015, Henrik Fomsgaard-Knudsen is registered as adm. dir. of 2care4 Generics ApS.
As of July 10, 2015, 2care4 Group ApS is registered as an owner of 2care4 Generics ApS with an ownership share of 100%.
2care4 Generics ApS was founded on July 10, 2015.
Companies in the same industry and area
CVR 25615697
CVR 28964080
CVR 16249092
CVR 31605822
CVR 36893419
companydata.dk